How to Buy Agilent Technologies Stock
Agilent Technologies Inc
Agilent Technologies is a diagnostic & research company located in California, United States, which is part of the Healthcare sector, and is traded under the ticker A on the NYSE exchange.
Agilent Technologies stock last closed at $138.32, down 0.03% from the previous day, and has increased 1.63% in one year. It has underperformed other stocks in the Diagnostics & Research industry by 0.15 percentage points. Agilent Technologies stock is currently +43.44% from its 52-week low of $96.43, and -13.7% from its 52-week high of $160.27.
There are currently 283.5M shares of A outstanding. The market cap of A is $39.21B. In the last 24 hours, 502,000 A shares were traded.
How to Buy Agilent Technologies Stock
Not sure how to invest in Agilent Technologies stock? Here's how.
- Choose where to buy Agilent Technologies stock: You need to decide on an online brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you choose where to buy Agilent Technologies stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit funds into your brokerage account: Choose your method of payment and add your info.
- Research Agilent Technologies stock: The Agilent Technologies ticker symbol is A. Is Agilent Technologies stock a good investment? Should you buy shares of A? How do A's underlying business fundamentals look? Do top analysts think Agilent Technologies is a good buy? Why has A's stock price moved recently? (Hint: Our stock market analysis website can help you evaluate if A is a good stock to buy).
- Place your A buy order: Decide if you will purchase A shares at the current market price or use a limit order to purchase A shares at a particular price.
- Get key alerts regarding your A position: Create a watchlist to key updates about your investment in Agilent Technologies shares.
Step 1: Choose where to buy Agilent Technologies stock
You need a brokerage account in order to access the NYSE market and buy A shares.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global markets: From Tech to Energy, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've selected your brokerage, you'll need to fill out some personal details so you can invest in A today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to open your new trading account.
- Send your info by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you have created your account on the best stock buying app, you need to deposit funds:
Check out the walkthrough below for more details depositing funds into your brokerage account.
Step 4: Research Agilent Technologies stock
Once you have identified the best place to buy Agilent Technologies stock, it's critical to evaluate their stock before you invest, so you actually understand the risk and upside.
Overview of key A info
Agilent Technologies Fundamentals
WallStreetZen was created to help average investors do more accurate fundamental analysis.
You can see all of the due diligence checks on A's stock page.
Is A stock undervalued?
Investors use many financial metrics, analyses, models, and charts to gauge A's true value.
Using relative valuations ratios:
- A may be overvalued based on its P/E ratio of 30.14x, relative to Diagnostics & Research industry P/E ratio of 22.51x
- A may be overvalued based on its P/B ratio of 5.82x, relative to Diagnostics & Research industry P/B ratio of 4.47x
- A could be overvalued based on its PEG ratio of 2.32x
You can access more valuation analysis on A's stock here.
A Financials at a glance
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the A balance sheet.
- Total A debt is lower than 5 years ago, relative to shareholder equity.
- A earnings of $1.55B is not sufficient to cover its interest payments.
- A's operating cash flow of $1.56B allows it to safely service it's debt of $3.35B.
- There are more short-term assets than long-term liabilities on the A balance sheet.
Negative Health Checks:
- A has a relatively high debt to equity ratio of 0.89.
- A profit margin has gone down from 19.8% to 18.8% in the past year.
Is it a good time to buy Agilent Technologies stock, according to Wall Street analysts?
Out of 12 Wall Street analysts who give recommendations on A, the consensus analyst rating on Agilent Technologies is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they investment advice.
Most Recent A Analyst Forecasts
Brandon Couillard, a top 25% analyst from Wells Fargo maintains A with a strong buy rating and raises their A price target from $150.00 to $175.00, on Nov 25, 2025.
Casey Woodring, a bottom 3% analyst from JP Morgan maintains A with a strong buy rating and raises their A price target from $165.00 to $180.00, on Nov 25, 2025.
Catherine Schulte, a top 12% analyst from Baird maintains A with a buy rating and raises their A price target from $142.00 to $165.00, on Nov 25, 2025.
Derik De Bruin, a top 12% analyst from Bank of America maintains A with a hold rating and raises their A price target from $150.00 to $165.00, on Nov 25, 2025.
Dan Brennan, a top 14% analyst from TD Cowen maintains A with a strong buy rating and raises their A price target from $150.00 to $162.00, on Oct 14, 2025.
TD Cowen's Dan Brennan raised their price target on Agilent Technologies (NYSE: A) by 8% from $150 to $162 on 2025/10/14. The analyst maintained their Strong Buy rating on the stock.
Agilent Technologies is expected to report its Q4 and FY 2025 earnings on 2025/11/24.
Brennan predicted FY 2026 organic guidance of about 5%, in line with consensus.
EBIT expansion is likely to be slightly below consensus at 70+ bp Y/Y, the analyst added, pointing out that their FY 2026 EPS estimate is below consensus.
Nonetheless, factors Brennan cited for their reiterated Buy rating included:
- Good Q4 results.
- A turnaround in biopharma.
- Idiosyncratic drivers.
- The likelihood of upside to FY 2026 forecasts.
You can dig deeper into what analysts are saying on the Agilent Technologies stock forecast page.
Metrics for Advanced A Traders
A Performance Metrics
Last year, A earnings were $1.30B. During the past five year, A's earnings have gone up by 14.52% per year. This was faster than the Diagnostics & Research industry average of 7.82%.
Last year, A revenue was $6.95B. During the last 5 year, A's revenue has increased by 5.41% per year. This was slower than the Diagnostics & Research industry average of 9.39%.
Dig into A's earnings and revenue performance here.
Who is buying/selling A?
Over the past year, executives and large shareholders at A have sold more shares than they have bought.
Mikael Dolsten, Director of A, was the latest A insider to sell. They sold $389,511.20 worth of A shares on Dec 1, 2025.
Get more info about who owns A shares here.
Can I rely on A as an income stream?
Agilent Technologies pays a dividend of 0.54%, compared to the Diagnostics & Research industry's average dividend yield of 0.66%. If you owned $1,000 worth of A stock, you would have received $5.38 last year.
Agilent Technologies dividend payments have consistently grown over the past decade and have remained stable.
Get more analysis about Agilent Technologies dividend yield and history here.
Get analysis from other traders
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Place your A buy order
There are two main options:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are mostly fine. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a specific dollar amount limit, place a limit order.
Press the Open Trade button and eToro will execute your order.
If you require additional info about buying stocks on eToro, watch the how to video below:
Step 6: Get key alerts regarding your A position
Now that you own some A shares, you'll want to stay up-to-date on your new investment.
Create a watchlist to track your A stock.
A Feed
How to Buy Stock in Agilent Technologies
To reiterate, here are the 6 steps to buy stock in Agilent Technologies:
- Choose where to buy Agilent Technologies stock
- Sign up for your brokerage account
- Deposit funds into your brokerage account
- Research Agilent Technologies stock
- Place your A buy order
- Get key alerts regarding your A position
If you require a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to get the latest scoop on your new investment in Agilent Technologies, create a watchlist on WallStreetZen today.
Trending Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.